September 24, 2020
Pliant Therapeutics
Pliant Therapeutics Presents Data at American Thoracic Society 2020 Virtual Sessions
September 23, 2020
bluebird bio
bluebird bio’s LentiGlobin™ for Sickle Cell Disease Gene Therapy (bb1111) Granted Priority Medicines (PRIME) Designation by European Medicines Agency
September 22, 2020
Decibel Therapeutics
Decibel Therapeutics Appoints Dr. Elisabeth Leiderman as Chief Financial Officer
September 22, 2020
Blueprint Medicines
Blueprint Medicines Announces Positive Top-line Results from EXPLORER and PATHFINDER Trials of AYVAKIT™ (avapritinib) in Patients with Advanced Systemic Mastocytosis
September 22, 2020
bluebird bio
U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb and bluebird bio Application for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, bb2121)